SAN DIEGO, California , Sept. 12, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the 2023 Cantor Fitzgerald Global Healthcare Conference , which takes place September 26-28, 2023 , at the InterContinental

SAN DIEGO , Aug. 07, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended June 30, 2023 . Second Quarter Highlights: Delivered a record 37,749 AVISE® CTD tests in the second quarter, an 8%

SAN DIEGO , July 26, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Canaccord Genuity 43 rd Annual Growth Conference, which takes place August 7-10, 2023 , at the InterContinental Boston Hotel in

SAN DIEGO , July 25, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended June 30, 2023 , before the market open on Monday, August 7, 2023 . John Aballi , Exagen’s President and Chief Executive

SAN DIEGO , July 24, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that Paul Kim has been appointed as a member of the Exagen Board of Directors, effective July 24, 2023 . Mr. Kim currently serves as Chief Financial Officer

SAN DIEGO , May 30, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the William Blair 43 r d Annual Growth Stock Conference , which takes place June 6-8, 2023 , in Chicago at the Loews Chicago Hotel .

Record Physician Demand for AVISE® CTD SAN DIEGO , May 15, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN)("Exagen"), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2023 . First Quarter Highlights: Delivered a record 37,312

SAN DIEGO , May 01, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of a campaign focusing on providers, patients and partnership activities that enhance the impactful work

SAN DIEGO , April 24, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended March 31, 2023 , after the market close on Monday, May 15, 2023 . John Aballi , Exagen’s President and Chief Executive

Record AVISE® CTD Volume in 2022 SAN DIEGO , March 20, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full year ended December 31, 2022 .